Stefano Gulla

Stefano Gulla

Oprichter bij Abcuro, Inc.

Commercial Services

Oorsprong van het eerstegraads netwerk van Stefano Gulla

EntiteitType entiteitIndustrie
13
Holding Company Miscellaneous Commercial Services 13

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Stefano Gulla via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Pharmaceuticals: Major

Robert A. Millman

Ya Jun Xu

Ya Jun Xu

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Director/Board Member

Investment Banks/Brokers

Jason Hafler

Corporate Officer/Principal

Investment Managers

Ryan Berry

Analyst-Equity

Biotechnology

Julius Knowles

Chief Executive Officer

Investment Managers

Jason Hafler

Private Equity Analyst

Investment Managers

Jason Hafler

Corporate Officer/Principal

College/University

Jason Hafler

Undergraduate Degree

Brandeis University College/University

Ya Jun Xu

Ya Jun Xu

Doctorate Degree

Doctorate Degree

Yale University College/University

Ryan Berry

Doctorate Degree

College/University

Ryan Berry

Undergraduate Degree

University of Augsburg College/University

Donald McCarthy

Undergraduate Degree

Miscellaneous Commercial Services

Julius Knowles

Corporate Officer/Principal

Investment Managers

Jason Hafler

Private Equity Investor

Investment Managers

Julius Knowles

Private Equity Investor

BASF Bioresearch Corp.

Ya Jun Xu

Corporate Officer/Principal

Miscellaneous Commercial Services

Jason Hafler

Corporate Officer/Principal

Pharmaceuticals: Major

Ya Jun Xu

Corporate Officer/Principal

Magdalene College College/University

Jason Hafler

Director/Board Member

Investment Managers

Julius Knowles

Corporate Officer/Principal

Albany Medical College College/University

Donald McCarthy

Graduate Degree

The College of Nanoscale Science & Engineering College/University

Donald McCarthy

Doctorate Degree

Other Consumer Services

Jason Hafler

Director/Board Member

Harvard Medical School College/University

Jason Hafler

Corporate Officer/Principal

Miscellaneous Commercial Services

Ya Jun Xu

Ya Jun Xu

Corporate Officer/Principal

Founder

Biotechnology

Julius Knowles

Director/Board Member

Beijing University of Chemical Technology College/University

Ya Jun Xu

Ya Jun Xu

Graduate Degree

Graduate Degree

Harvard T.H. Chan School of Public Health College/University

Ya Jun Xu

Graduate Degree

Investment Trusts/Mutual Funds

Jorge Escobar

Director/Board Member

RaNA Therapeutics LLC

Jason Hafler

Corporate Officer/Principal

KEROS THERAPEUTICS, INC. Pharmaceuticals: Major

Julius Knowles

Director/Board Member

Pharmaceuticals: Major

Jason Hafler

Director/Board Member

Investment Managers

Ya Jun Xu

Consultant / Advisor

Investment Managers

Ya Jun Xu

President

Pharmaceuticals: Major

Ya Jun Xu

Director/Board Member

Biotechnology

Jason Hafler

Director/Board Member

Biotechnology

Ya Jun Xu

Consultant / Advisor

Investment Managers

Ryan Berry

Private Equity Analyst

ICOSAVAX, INC. Pharmaceuticals: Major

Jason Hafler

Director/Board Member

Biotechnology

Ya Jun Xu

Director/Board Member

Biotechnology

Jason Hafler

Julius Knowles

Director/Board Member

Director/Board Member

Biotechnology

Jason Hafler

Corporate Officer/Principal

Miscellaneous Commercial Services

Ya Jun Xu

Director/Board Member

Beacon Hill Nursery School, Inc.

Jason Hafler

Director/Board Member

Biotechnology

Jason Hafler

Director/Board Member

Global Founders Capital/Us/ Investment Managers

Donald McCarthy

Private Equity Investor

Amp Bioresearch LLC

Donald McCarthy

Consultant / Advisor

Statistieken

Internationaal

Verenigde Staten 42
China 5
Duitsland 2
Bermuda 2
Verenigd Koninkrijk 2

Sectoraal

Health Technology 17
Finance 13
Consumer Services 13
Commercial Services 5
Technology Services 2

Operationeel

Director/Board Member 49
Corporate Officer/Principal 31
Director of Finance/CFO 11
Undergraduate Degree 9
Private Equity Investor 8
  1. Beurs
  2. Insiders
  3. Stefano Gulla
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU